Nina Geib

Title: Nina Geib: Innovator in Vaccine Development

Introduction

Nina Geib is a prominent inventor based in Zurich, Switzerland. She has made significant contributions to the field of vaccine development, particularly through her innovative work with lipopeptides. Her research focuses on creating synthetic virus-like particles that can serve as effective vaccines against infectious diseases.

Latest Patents

Nina Geib holds one patent related to her invention of lipopeptides. This invention consists of a peptide chain that includes a parallel coiled-coil domain, a proline-rich peptide antigen, and a lipid moiety, all covalently linked. These components aggregate to form synthetic virus-like particles. The proline-rich peptide antigens contain both negatively and positively charged amino acids, with at least 15% of the amino acids being proline. These synthetic virus-like particles, which carry proline-rich antigens derived from pneumococcal proteins, are particularly useful as vaccines against infectious diseases caused by Gram-positive bacteria.

Career Highlights

Throughout her career, Nina Geib has worked with esteemed institutions such as Universität Zürich and the Swiss Tropical and Public Health Institute. Her work has been instrumental in advancing the understanding and development of vaccines.

Collaborations

Nina has collaborated with notable colleagues, including Arin Ghasparian and Armando Zuniga. Their combined expertise has contributed to the success of her research initiatives.

Conclusion

Nina Geib's innovative work in vaccine development highlights her significant role in the scientific community. Her contributions to the field of lipopeptides and synthetic virus-like particles are paving the way for new advancements in combating infectious diseases.